Chordia Therapeutics,Inc
190A | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 藤沢市村岡東２−２６−１
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Chordia Therapeutics, Inc. is a pioneering Japanese biotechnology company dedicated to advancing the field of therapeutics through innovative research and development. The company focuses on discovering and deploying novel treatments that address unmet medical needs, leveraging cutting-edge technologies and a deep understanding of biological processes. With a commitment to improving patient outcomes, Chordia Therapeutics endeavors to create impactful solutions in various therapeutic areas. The company is driven by a mission to enhance healthcare through scientific excellence and collaboration, ultimately striving to transform the lives of patients worldwide.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-16 02:45 |
Inside Information Statement
臨時報告書
|
Japanese | 20.2 KB | |
| 2025-04-11 04:50 |
Interim Report
半期報告書－第8期(2024/09/01－2025/08/31)
|
Japanese | 144.4 KB | |
| 2025-04-11 04:50 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-12-17 07:30 |
Regulatory News Service
訂正確認書
|
Japanese | 8.7 KB | |
| 2024-11-29 07:37 |
Inside Information Statement
臨時報告書
|
Japanese | 23.1 KB | |
| 2024-11-29 07:36 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-11-29 07:35 |
Internal Control over Financial Reporting
内部統制報告書－第7期(2023/09/01－2024/08/31)
|
Japanese | 21.2 KB | |
| 2024-11-29 07:34 |
Annual Report
有価証券報告書－第7期(2023/09/01－2024/08/31)
|
Japanese | 2.8 MB | |
| 2024-07-16 06:55 |
Quarterly Report
四半期報告書－第7期第3四半期(2024/03/01－2024/05/31)
|
Japanese | 123.4 KB | |
| 2024-07-16 06:55 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2024-06-06 08:00 |
Regulatory News Service
訂正有価証券届出書（新規公開時）
|
Japanese | 2.9 MB | |
| 2024-05-29 04:00 |
Regulatory News Service
訂正有価証券届出書（新規公開時）
|
Japanese | 2.9 MB | |
| 2024-05-10 08:00 |
Prospectus
有価証券届出書（新規公開時）
|
Japanese | 5.7 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |